Singapore: Taiwan's TWi Pharmaceuticals has recieved ANDA approval of the generic equivalent to Procardia XL (Nifedipine...
Singapore: Japan-based Takeda Pharmaceutical and Amsterdam-based Norgine has received Japanese Ministry of Health, Labo...
Singapore: About two months after the US Food and Drug Administration (US FDA) issued a Form 483 to Wockhardt for drug q...
Singapore: Horizon, an Irish engineerng consultancy firm, has completed testing of its new tracking system that aims at ...
Singapore: Mylan Pharmaceuticals received final approval from the US FDA for its abbreviated new drug application (ANDA)...
Singapore: Japan's Daiichi Sankyo and Ranbaxy Laboratories have plans to integrate their business operations in Thailand...
Singapore: AstraZeneca and Bristol-Myers Squibb have recieved U.S. Food and Drug Administration (FDA) approval for diabe...
New Delhi: Ranbaxy issued an advisory claiming that all their products in the Indian and global markets are safe and eff...
Singapore: Vietnam has seen a substantial increase in the number of rabies fatalities from 34 deaths in 2003 to 131 deat...
Singapore: Merely a month after Indian drug major, Ranbaxy, pleaded guilty of having misled the USFDA investigations, se...
Singapore: Mundipharma has entered a license agreement with Japan-based Shionogi for the exclusive rights to develop, ma...
Singapore: Britian's leading drug maker, GlaxoSmithKline has filed for US Food and Drug Administration (US FDA) approval...
Singapore: WHO and Global Fund to Fight AIDS, TB and Malaria have stressed on strains of tuberculosis with resistance to...
Singapore: US based Avanir Pharmaceuticals has entered into a settlement agreement with India's Wockhardt to resolve pen...
Singapore: Taiwan-based TWi Pharmaceuticals has received tentative approval for its Abbreviated New Drug Application (AN...
Singapore: The generics unit of Novartis, Sandoz, has launched a late-stage trial with its biosimilar version of Amgen's...
Singapore: US based Par Pharmaceutical has entered into agreements with Watson Pharmaceuticals and Actavis Group to purc...
In a landmark decision, Hyderabad-based NATCO Pharma has been granted compulsory license for Sorafenib Tosylate sold und...
